Ricin-IG

N/A

Report date: 2025/03/20 09:59:01

Base Information

Drug NameRicin-IG
Drug Alias Nameanti-ricin mAbs (Cangene)antibody-based ricin therapy (Cangene/Twinstrand Therapeutics)immune globulin (Cangene)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPoisoning
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCangene Corp
China Registration ClassN/A

Develop Information

Active CompaniesEmergent Biosolutions Inc
Inactive CompaniesTwinstrand Therapeutics IncCangene Corp
Active IndicationsPoisoning
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A